Janus Global Life Sciences Fund (JNGLX)
Sector Experts Seeking Growth and Innovation in Health Care


Who Should Consider This Fund?

Investors looking for exposure to a fast-growing area of the overall market through companies that we believe are either driving advancements in the healthcare field or benefiting from demographic trends.

Asset ClassGlobal/International
Share Class D
target risk very aggressive

Funds are placed on the risk tolerance spectrum to demonstrate the wide spectrum of risk levels among asset classes in which they are expected to typically invest. The spectrum is for informational purposes only, is not intended to be forward looking and is subject to change. 

Fund Facts
Inception Date12/31/1998
NAV (As of 4/28/17)$51.60
Daily NAV Change$-0.01
Daily NAV % Change-0.02%
Total Net Assets (As of 3/31/17)$3.42B
Annual Expense Ratio
(As of fiscal year end 9/30/16)
GROSS 0.84%
NET 0.84%
Morningstar Fee Level
(As of 3/31/17)
Fee Level Group
(out of 304 funds)
Specialty No Load

Morningstar (As of 3/31/17)
CategoryUS Fund Health
Overall Rating™
(Based on risk-adjusted returns)
126 Funds Rated
View all Ratings
Style Box
Performance (As of 3/31/17)
YTD (As of 4/28/17) 14.03%
1 Year 13.40%
3 Year 10.19%
5 Year 19.34%
10 Year 12.96%

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Client Commitment

This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers. 

Client Commitment Video

Fund Overview

Data as of 3/31/17. Index represents the MSCI World Health Care Index.

TOP HOLDINGS (% of Fund)

Eli Lilly & Co 3.59
Amgen Inc 3.19
Sanofi 2.95
Shire PLC (ADR) 2.94
AstraZeneca PLC 2.88
Celgene Corp 2.80
Aetna Inc 2.74
Regeneron Pharmaceuticals Inc 2.49
Allergan PLC 2.37
Boston Scientific Corp 2.20


Health Care 97.16 100.00
Industrials 0.96 -
US Industrials 0.50 -
Cash & Equivalents 1.38 -

Why Invest in the Fund


The long-term drivers of growth in the health care sector include powerful global demographic trends rapidly accelerating and compounding innovation and the globalization of health care. Within this environment, the Fund seeks to invest in growth companies that are addressing unmet medical needs or making the health care system more efficient and affordable.


Our dedicated team of analysts has more than 100 years of combined experience investing in health care companies. In this complex and rapidly growing sector, we believe it is critical to have an experienced team that seeks to understand both the science and the business of the companies in which they invest.


We believe the combination of deep fundamental research and disciplined portfolio construction will lead to consistently strong results relative to both the health care sector and the broader equity market. The Fund is balanced across the subsectors of health care and diversified across market-cap segments and geographies.


Andy Acker, CFA

Andy Acker, CFA

Fund Manager since 2007
Industry since 1996

Ethan Lovell

Ethan Lovell

Fund Manager since 2016
Industry since 1994